Vulvar Dysplasia
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests (NCT05536843) | University of Mississippi Medical Center | 2023-01-01 |
| Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. (NCT03061435) | Dr. Danielle Vicus | 2021-02-01 |
| OCT-AF Imaging of Pre-cancers of Vulva and Cervix (NCT03285841) | British Columbia Cancer Agency | 2019-07-25 |
| Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) (NCT03792516) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-04-17 |
| Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) (NCT03180684) | Inovio Pharmaceuticals | 2017-08-31 |
| A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia (NCT00394758) | University Hospitals Cleveland Medical Center | 2000-01-01 |
Track Vulvar Dysplasia automatically
Every clearance here is in the API, with alerts when new ones post.